PICKERING GRANT 4
4 · LeonaBio, Inc. · Filed Jun 24, 2026
Research Summary
AI-generated summary of this filing
LeonaBio Director Grant Pickering Receives 28,000-Share Option Grant
What Happened Director Grant Pickering received a grant/award of 28,000 derivative shares (reported as transaction code A) on 2026-06-23. The filing shows a $0.00 acquisition price because this is an equity award (option) granted as compensation rather than an open‑market purchase. No immediate cash transaction or sale occurred.
Key Details
- Transaction date: 2026-06-23; Form 4 filed: 2026-06-24 (timely).
- Grant: 28,000 shares reported as an award/derivative (code A) at $0.00.
- Vesting: The option vests on the earlier of (i) June 23, 2027, or (ii) the day before the next annual meeting of stockholders after June 22, 2026 (per footnote).
- Plan/policy: Granted pursuant to the Issuer's Outside Director Compensation Policy.
- Shares owned after transaction: Not disclosed in the provided filing.
- Filing status: Timely (no late filing flag).
Context This is a routine director compensation option award, not an open‑market buy or sale. As a derivative award, the economic benefit depends on vesting and any future exercise terms; it does not represent immediate proceeds or a market purchase. Such grants are common for non‑executive directors and are primarily compensation, not necessarily an indicator of personal market sentiment.
Insider Transaction Report
- Award
Stock Option (Right to Buy)
[F1]2026-06-23+28,000→ 28,000 totalExercise: $8.35Exp: 2036-06-22→ Common Stock (28,000 underlying)
Footnotes (1)
- [F1]The shares subject to the option will vest on the earlier of (i) June 23, 2027, or (ii) the day immediately before the date of the next annual meeting of the Issuer's stockholders that occurs after June 22, 2026. The option reported was granted pursuant to the terms of the Issuer's Outside Director Compensation Policy.